Tocilizumab versus methotrexate in moderate to severe rheumatoid arthritis

被引：1
|
作者：
Aarat M. Patel
Larry W. Moreland
机构：
[1] University of Pittsburgh,Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology
[2] Children’s Hospital,Division of Rheumatology and Clinical Immunology
[3] University of Pittsburgh,undefined
来源：
Current Rheumatology Reports | 2009年 / 11卷 / 5期
关键词：
Tocilizumab; Active Rheumatoid Arthritis; Placebo Tablet; ACR20 Response; Improvement Criterion;
D O I：
10.1007/s11926-009-0057-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 314
页数：1
相关论文
共 50 条
  • [1] Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
    Jones, G.
    Sebba, A.
    Gu, J.
    Lowenstein, M. B.
    Calvo, A.
    Gomez-Reino, J. J.
    Siri, D. A.
    Tomsic, M.
    Alecock, E.
    Woodworth, T.
    Genovese, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 88 - 96
  • [2] Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
    Hushaw, Linda L.
    Sawaqed, Ray
    Sweis, Ghaleb
    Reigle, Jori
    Gopal, Anjali
    Brandt, Daniel
    Sweis, Nadia
    Curran, James
    Niewold, Timothy B.
    Sweiss, Nadera J.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 143 - 152
  • [3] The Efficacy Of Etanercept In Combination With Methotrexate In Moderate To Severe Rheumatoid Arthritis Is Not Dependent On The Dosage Of Methotrexate
    Huizinga, T. W. J.
    Brock, Fiona
    Kerkmann, Urs
    Gallo, Gaia
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S613 - S614
  • [4] TOCILIZUMAB IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW OF EFFICACY AND SAFETY
    Nadzieja-Koziol, A.
    Leszczynska, D.
    Kowalczyk, M.
    Malysiak-Szpond, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S240 - S240
  • [5] COST-UTILITY OF TOCILIZUMAB MONOTHERAPY IN METHOTREXATE INTOLERANT/CONTRA-INDICATED, MODERATE/SEVERE RHEUMATOID ARTHRITIS PATIENTS IN PORTUGAL
    Monteiro, I
    Cafe, A.
    Encarnacao, R.
    Diamantopoulos, A.
    Dejonckheere, F.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A447 - A447
  • [6] Tocilizumab versus adalimumab for rheumatoid arthritis
    De Vita, Salvatore
    [J]. LANCET, 2013, 381 (9877): : 1515 - 1517
  • [7] Rituximab versus tocilizumab for rheumatoid arthritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (03): : E174 - E174
  • [8] Tocilizumab versus adalimumab for rheumatoid arthritis
    Felson, David T.
    [J]. LANCET, 2013, 382 (9890): : 394 - 395
  • [9] Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
    Gallo, G.
    Brock, F.
    Kerkmann, U.
    Kola, B.
    Huizinga, T. W. J.
    [J]. RMD OPEN, 2016, 2 (01):
  • [10] EFFICACY OF TOCILIZUMAB FOR CORTICOSTEROID AND METHOTREXATE SPARING IN RHEUMATOID ARTHRITIS
    Athanassiou, Panagiotis
    Gatsiou, Marina
    Athanassiou, Lambros
    Tsakiridis, Pavlos
    Tzanavari, Aikaterini
    Devetzi, Eirini
    Katsavouni, Charoula
    Kostoglou-Athanassiou, Ifigenia
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1642 - 1642
12345